Trials / Not Yet Recruiting
Not Yet RecruitingNCT07231744
Study of STLX-2012 in Healthy Volunteers
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of STLX-2012 in Healthy Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Stelexis BioSciences · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to establish the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single IV dose of STLX-2012.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | STLX-2012 | STLX-2012 IV |
| OTHER | Placebo | Placebo arm |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07231744. Inclusion in this directory is not an endorsement.